New York State Common Retirement Fund’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.66M Sell
524,504
-89,574
-15% -$1.18M 0.01% 902
2026
Q1
$8.46M Buy
614,078
+146,236
+31% +$2.2M 0.01% 800
2025
Q4
$8.44M Buy
467,842
+322,409
+222% +$5.79M 0.01% 809
2025
Q3
$2.69M Buy
145,433
+55,863
+62% +$878K ﹤0.01% 1332
2025
Q2
$1.43M Sell
89,570
-42,654
-32% -$760K ﹤0.01% 1527
2025
Q1
$2.57M Sell
132,224
-57,375
-30% -$1.21M ﹤0.01% 1285
2024
Q4
$4.18M Buy
189,599
+4,838
+3% +$93.1K 0.01% 1165
2024
Q3
$3.11M Buy
184,761
+102,323
+124% +$1.52M ﹤0.01% 1263
2024
Q2
$985K Sell
82,438
-4,943
-6% -$55.2K ﹤0.01% 1774
2024
Q1
$968K Buy
87,381
+71,941
+466% +$734K ﹤0.01% 1789
2023
Q4
$134K Hold
15,440
﹤0.01% 2615
2023
Q3
$118K Buy
15,440
+9,635
+166% +$72.3K ﹤0.01% 2637
2023
Q2
$41.8K Hold
5,805
﹤0.01% 3165
2023
Q1
$35.4K Buy
+5,805
New +$31.5K ﹤0.01% 3059

Other funds holding CLBT

New York State Common Retirement Fund's CLBT Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Cellebrite (CLBT) stake by 15% in Q2 2026, selling an estimated $1.18M and leaving 524,504 shares worth $7.66M. The position accounts for 0.01% of the portfolio, ranked #902.

New York State Common Retirement Fund first reported a position in CLBT in Q1 2023 and has held it in 14 quarters since. The position peaked at $8.46M in Q1 2026. 69 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • New York State Common Retirement Fund held 524,504 shares of Cellebrite worth $7.66M as of Q2 2026.
  • New York State Common Retirement Fund sold 89,574 Cellebrite shares in Q2 2026, an estimated $1.18M.
  • Cellebrite made up 0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #902 holding.
  • New York State Common Retirement Fund first reported a position in Cellebrite in Q1 2023 and has held it in 14 quarters since.
  • New York State Common Retirement Fund's Cellebrite position peaked at $8.46M in Q1 2026.
  • 69 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.